XNCR
Price:
$12.64
Market Cap:
$937.15M
Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable therapies currently in use, such as Sotrovimab, which targets the SARS-CoV-2 virus; Ultomiris, prescribed for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi, indicated for individuals with relapsed or refractory diffuse large B-cell lymphoma. Xencor maintains a rob...[Read more]
Industry
Biotechnology
IPO Date
2013-12-03
Stock Exchange
NASDAQ
Ticker
XNCR
According to Xencor, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.57. This represents a change of 8.82% compared to the average of 6.04 of the last 4 quarters.
The mean historical Current Ratio of Xencor, Inc. over the last ten years is 5.99. The current 6.57 Current Ratio has changed 10.87% with respect to the historical average. Over the past ten years (40 quarters), XNCR's Current Ratio was at its highest in in the June 2023 quarter at 13.30. The Current Ratio was at its lowest in in the September 2016 quarter at 1.00.
Average
5.99
Median
6.13
Minimum
1.33
Maximum
10.58
Discovering the peaks and valleys of Xencor, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 157.35%
Maximum Annual Current Ratio = 10.58
Minimum Annual Increase = -40.74%
Minimum Annual Current Ratio = 1.33
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 6.25 | -5.33% |
| 2024 | 6.61 | -10.20% |
| 2023 | 7.36 | -30.45% |
| 2022 | 10.58 | 76.32% |
| 2021 | 6.00 | 13.89% |
| 2020 | 5.27 | -37.22% |
| 2019 | 8.39 | 43.10% |
| 2018 | 5.86 | 157.35% |
| 2017 | 2.28 | 70.94% |
| 2016 | 1.33 | -40.74% |
The current Current Ratio of Xencor, Inc. (XNCR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
6.74
5-year avg
7.36
10-year avg
5.99
Xencor, Inc.’s Current Ratio is greater than Nurix Therapeutics, Inc. (6.01), greater than Oculis Holding AG (5.18), greater than Kodiak Sciences Inc. (3.54), greater than Phathom Pharmaceuticals, Inc. (2.21), greater than UroGen Pharma Ltd. (4.69), less than AnaptysBio, Inc. (7.58), less than Nektar Therapeutics (10.21), less than Tango Therapeutics, Inc. (27.38), greater than Mind Medicine (MindMed) Inc. (4.69), greater than BridgeBio Oncology Therapeutics Inc. (6.16),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.01 | $1.52B | |
| 5.18 | $641.44M | |
| 3.54 | $1.91B | |
| 2.21 | $867.74M | |
| 4.69 | $1.64B | |
| 7.58 | $2.48B | |
| 10.21 | $1.19B | |
| 27.38 | $3.48B | |
| 4.69 | $1.56B | |
| 6.16 | $605.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xencor, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xencor, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Xencor, Inc.'s Current Ratio?
How is the Current Ratio calculated for Xencor, Inc. (XNCR)?
What is the highest Current Ratio for Xencor, Inc. (XNCR)?
What is the 3-year average Current Ratio for Xencor, Inc. (XNCR)?
What is the 5-year average Current Ratio for Xencor, Inc. (XNCR)?
How does the current Current Ratio for Xencor, Inc. (XNCR) compare to its historical average?